Baicalin upregulates the genetic expression of antioxidant enzymes in Type-2 diabetic Goto-Kakizaki rats

Life Sciences

Volumn 88, Issue 23-24, 2011, Pages 1016-1025

  Waisundara, Viduranga Y ^a   Siu, Sing Yung ^b   Hsu, Annie ^b   Huang, Dejian ^a   Tan, Benny K H ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Antioxidant; Baicalin; Diabetes; Goto Kakizaki; Metformin

Indexed keywords

BAICALIN; CARBONYL DERIVATIVE; CATALASE; GLUCOSE; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE; METFORMIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG ACTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; HEART; IN VIVO STUDY; LIVER; MICROARRAY ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PANCREAS; PROTEIN CARBONYLATION; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE LEVEL; TRANSMISSION ELECTRON MICROSCOPY; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FLAVONOIDS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; LIPID PEROXIDES; METFORMIN; MICROARRAY ANALYSIS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIGLYCERIDES; UP-REGULATION;

RATTUS;

EID: 79957556792     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2011.03.009     Document Type: Article

References (45)

1. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006;444:337-41.
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-20. (Pubitemid 34000785)
3. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005;54:1615-25. (Pubitemid 40770750)
4. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, et al. Defective intracellular antioxidant enzyme production in type 2 diabetic patients with nephropathy. Diabetes 2000;49:2170-7.
5. Chan DC. Mitochondrial dynamics in disease. N Engl J Med 2001;356:1708-9.
6. Chan FL, Choi HL, Chen ZY, Chan PSF, Huang Y. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin. Cancer Lett 2000;160:219-28.
7. Cheng KT, Hou WC, Huang YC, Wang LF. Baicalin induces differential expression of cytochrome C oxidase in human lung H441 cell. J Agric Food Chem 2003;51: 7276-9.
8. Di Mauro S, Schon EA. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656-68. (Pubitemid 36741594)
9. Gao Z, Xu H, Chen X, Chen H. Antioxidant status and mineral contents in tissues of rutin and baicalin fed rats. Life Sci 2003;73:1599-607. (Pubitemid 36831141)
10. Gershell L. Type 2 diabetes market. Nature 2005;4:367-8. (Pubitemid 40704113)
11. Halliwell B. Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies? Arch Biochem Biophys 2009;476:107-12.
12. Halliwell B, Hoult JR, Blake DR. Oxidants, inflammation, and anti-inflammatory drugs. FASEB J 1998;2:2867-73.
13. Halliwell B, Rafter J, Jenner A. Health promotion by flavonoids, tocopherols, tocotrienols, and other phenols: direct or indirect effects? Antioxidant or not? Am J Clin Nutr 2005;81:268S-76S.
14. Hay KX, Waisundara VY, Yong Z, Han MY, Huang DJ. CdSe nanocrystals as hydroperoxide scavengers: a new approach to highly sensitive quantification of lipid hydroperoxides. Small 2007;3:290-3.
15. Hoen PAC, Van der Lans CAC, Van Eck M, Bijsterbosch MK, Van Berkel TJC, Twisk J. Aorta of ApoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res 2003;93:262-9. (Pubitemid 36993238)
16. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedov M, Jahangir A, Terzic A. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J 2002;16:1010-6. (Pubitemid 34753507)
17. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006;440:944-8.
18. Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med 2006;40:183-92. (Pubitemid 43069343)
19. Korshunov SS, Skulachev VP, Starkov AA. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett 1997;416:15-8. (Pubitemid 27470791)
20. Lapidot T, Walker MD, Kanner J. Can apple antioxidants inhibit tumor cell proliferation? Generation of H2O2 during interaction of phenolic compounds with cell culture media. J Agric Food Chem 2002;50:3156-60. (Pubitemid 34533616)
21. Le Couteur DG, Cogger VC, MarkusAM, Harvey PJ, Yin ZL,McLean AJ. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001;33:537-43. (Pubitemid 32185214)
22. Lee JM, Peuler JD. A possible indirect sympathomimetic action of metformin in the arterial vessel wall of spontaneously hypertensive rats. Life Sci 2001;69:1085-92. (Pubitemid 32701919)
23. Li HT, Wu XD, Davey AK, Wang JP. Anti-hyperglycemic effects of baicalin on streptozotocin-nicotinamide induced diabetic rats. Phytother Res 2010;36: 1155-60.
24. Lin Y, Berg AH, Iyengar P, Lam TK, Giacca A, Combs TP, et al. The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 2005;280:4617-26. (Pubitemid 40288630)
25. Long LH, Clement MV, Halliwell B. Artifacts in cell culture: rapid generation of hydrogen peroxide on addition of (-)-epigallocatechin, (-)-epigallocatechin gallate, (+)- catechin, and quercetin to commonly used cell culture media. Biochem Biophys Res Commun 2000;273:50-3. (Pubitemid 30426861)
26. Lopez-Llusch G, Hunt N, Jones B, Zhu M, Jamieson H, Hilmer S, et al. Calorie restriction induces mitochondrial biogenesis and bioenergetic efficiency. Proc Nat Acad Sci USA 2006;103:1768-73. (Pubitemid 43228768)
27. Martin-Gallan P, Carrascosa A, Gussinye M, Dominguez C. Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 2003;34:1563-74. (Pubitemid 36638716)
28. Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P. Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab 2000;85:2970-3. (Pubitemid 32269184)
29. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA (1c). Diabetes Care 2003;26:881-5. (Pubitemid 36929359)
30. Ng TB, Liu F, Wang ZT. Antioxidative activity of natural products from plants. Life Sci 2000;66:709-23. (Pubitemid 30077864)
31. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, et al. Normalising mitochondrial superoxide production blocks three pathways of hyperglycaemia damage. Nature 2000;404:787-90. (Pubitemid 30212409)
32. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with Type 2 diabetes. N Engl J Med 2004;350:664-71. (Pubitemid 38364625)
33. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med 2004;350: 2438-40. (Pubitemid 38736540)
34. Salvemini D, Wang ZQ, Zweier JL, Samouilov A, Macarthur H, Misko TP, et al. A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science 1999;286:304-6. (Pubitemid 29484695)
35. Scott JA, King GL. Oxidative stress and antioxidant treatment in diabetes. Ann NY Acad Sci 2004;1031:204-13. (Pubitemid 40361755)
36. Suckow MA, Franklin CL, Weisbroth SH. Clinical pathology of the rat. The Laboratory Rat. Burlington MA: Elsevier Inc.; 2006.
37. The Diabetes Control and Complication Trial (DCTT)/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-9.
38. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352: 837-53.
39. Varvarovska J, Racek J, Stozicky F, Soucek J, Trefil L, Pomahacova R. Parameters of oxidative stress in children with type 2 diabetes mellitus and their relatives. J Diabetes Complications 2003;17:7-10. (Pubitemid 36042785)
40. Waisundara VY, Hsu A, Huang DJ, Tan BKH. Scutellaria baicalensis enhances the antidiabetic activity of metformin in streptozotocin-induced diabetic Wistar Rats. Am J Chin Med 2008;36:517-40. (Pubitemid 351818895)
41. Waisundara VY, Hsu A, Tan BKH, Huang DJ. Baicalin improves antioxidant status of streptozotocin-induced diabetic Wistar rats. J Agric Food Chem 2009a;57: 4096-102.
42. Waisundara VY, Hsu A, Huang DJ, Tan BKH. Baicalin reduces mitochondrial damage in streptozotocin-induced diabetic Wistar rats. Diabetes Metab Res Rev 2009b;25: 671-7.
43. West IC. Radicals and oxidative stress in diabetes. Diabetes Med 2000;17:171-80. (Pubitemid 30212288)
44. Williamson G, Barron D, Shimoi K, Terao K. In vitro biological properties of flavonoid conjugates found in vivo. Free Radic Res 2005;39:457-69.
45. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004;430:686-9. (Pubitemid 39061685)